- Home
- PGP vs BTMD Comparison
PGP vs BTMD Comparison
Compare PGP & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PGP | BTMD |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.9M | 64.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | PGP | BTMD |
|---|---|---|
| Price | $9.33 | $2.09 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 28.6K | ★ 138.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 10.84% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $197,191,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.37 |
| P/E Ratio | ★ N/A | $3.12 |
| Revenue Growth | N/A | ★ 6.38 |
| 52 Week Low | $6.56 | $2.02 |
| 52 Week High | $9.41 | $4.75 |
Technical Indicators
Market Signals| Indicator | PGP | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 56.92 | 43.18 |
| Support Level | $9.20 | $2.02 |
| Resistance Level | $9.41 | $2.37 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 72.09 | 33.33 |
Price Performance
Historical ComparisonAbout PGP Pimco Global StocksPlus & Income Fund of Beneficial Interest
PIMCO Global Stocksplus & Income Fund is a closed-end management investment company. The objective of the fund is to seek a total return comprised of current income, current gains, and long-term capital appreciation. The fund invests a majority of the fund's net assets in a combination of securities and instruments that provide exposure to stocks and or produce income.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.